𝔖 Bobbio Scriptorium
✦   LIBER   ✦

219 Results of a one-year international phase IIB comparative trial of telbivudine, lamivudine, and the combination, in patients with chronic hepatitis B

✍ Scribed by Ching-Lung Lai; Nancy W.Y. Leung; Eng-Kiong Teo; Florence Wong; Hie-Wan Hann; Steven Han; Thierry Poynard; Maureen Myers

Book ID
119530128
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
151 KB
Volume
38
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Telbivudine versus lamivudine in Chinese
Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial
✍ Jinlin Hou; You-Kuan Yin; Daozhen Xu; Deming Tan; Junqi Niu; Xiaqiu Zhou; Yuming πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Chronic hepatitis B and its life-threatening sequelae are highly prevalent in China. There is a need for effective new therapies to suppress hepatitis B virus (HBV) replication and ameliorate liver disease. In this study, we compared the efficacy of telbivudine, a nucleoside analogue, with lamivudin